Citadel Advisors
FRLN

Citadel Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Citadel Advisors’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$53.7K Buy
2022
Q4 		$11.8K Buy
2021
Q3 		– Sell
2021
Q2 		$108K Buy
2020
Q4 		– Sell
2020
Q3 		$398K Buy